SOURCE: PalliaTech

April 07, 2014 08:00 ET

PalliaTech Scientist Named Medical Cannabis Researcher of the Year

Americans for Safe Access Honors Noel Palmer, PhD.

WASHINGTON, DC--(Marketwired - April 07, 2014) - PalliaTech, a phytomedical technology company, announced today that the company's director of research and development, Dr. Noel Palmer (PhD.), has been named Medical Cannabis Researcher of the Year by Americans for Safe Access (ASA). The nation's leading medical Cannabis advocacy group, ASA honored Dr. Palmer along with CNN's Dr. Sanjay Gupta (Journalist of the Year), Representative Earl Blumenauer (Elected Official of the Year) and other leaders at the group's National Medical Cannabis Unity Conference.

"Like ASA, we are committed to providing patients in need of palliative relief with safe access to the therapeutic benefits of cannabinoid medicines," said Dr. Palmer. "I'm honored to be recognized for my work in this area by the nation's most effective advocate for the legal and responsible use of Cannabis as a medicine."

Dr. Palmer is an expert in plant and soil chemistry with experience in testing and studying medical Cannabis. At PalliaTech, he directs proprietary research and development into medical device technology, plant genetics and the identification, extraction and reverse engineering of phytochemicals as well as agricultural optimization of Cannabis cultivation. He is also lab director of PhytaTech CO, an independent Cannabis testing laboratory based in Denver, Colorado. 

PalliaTech, Inc. is a phytomedical technology company based on Long Island, NY, that is dedicated to unlocking the therapeutic value of medical Cannabis by introducing medical and pharmaceutical standards to one of the fastest-growing healthcare markets. PalliaTech develops medical technology, conducts phytochemical research and laboratory testing, and provides science-based products and services to patients, physicians, laboratories, cultivators, dispensaries and government agencies.

Contact Information